No Data
No Data
No Data
PaxMedica Announces Resignation of Key Executives
PaxMedica Announces Receives Notification to Grant Patent Right in China
PaxMedica | 10-Q: Q2 2024 Earnings Report
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
Express News | PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on Pax-101
PaxMedica | 10-Q: Q1 2024 Earnings Report